Literature DB >> 17635391

Transcranial Doppler and anesthetics.

V Fodale1, D Schifilliti, A Conti, T Lucanto, G Pino, L B Santamaria.   

Abstract

Transcranial Doppler (TCD) is widely used to investigate the effects of anesthetic drugs on cerebral blood flow. Its repeatability and non-invasivity makes it an ideal, first choice method. Anesthesia providers are required to be conscious of the cerebral hemodynamic effects of drugs given in their practice, especially in neurosurgery and in subjects with impaired brain functions. The purpose of this review is to present the basic concepts of the TCD technique and the effects on cerebral hemodynamics of the most popular anesthetic drugs evaluated using TCD ultrasonography.

Entities:  

Mesh：

Substances：

Year:  2007        PMID： 17635391     DOI： 10.1111/j.1399-6576.2007.01355.x

Source DB:  PubMed          Journal:  Acta Anaesthesiol Scand        ISSN： 0001-5172            Impact factor:   2.105


  4 in total

Review 1.  Transcranial Doppler Ultrasonography as a Diagnostic Tool for Cerebrovascular Disorders.

Authors:  Yuanmei Pan; Wenbin Wan; Minjie Xiang; Yangtai Guan
Journal:  Front Hum Neurosci       Date:  2022-04-29       Impact factor: 3.473

2.  Evaluation of cerebrovascular carbon dioxide reactivity in patients with diabetes mellitus under sedative doses of propofol.

Authors:  Chikara Kawauchi; Yuji Kadoi; Hiroshi Hinohara; Fumio Kunimoto; Shigeru Saito
Journal:  J Anesth       Date:  2008-11-15       Impact factor: 2.078

3.  Comparison of phase-contrast MR imaging and endovascular sonography for intracranial blood flow velocity measurements.

Authors:  J J Schneiders; S P Ferns; P van Ooij; M Siebes; A J Nederveen; R van den Berg; J van Lieshout; G Jansen; E vanBavel; C B Majoie
Journal:  AJNR Am J Neuroradiol       Date:  2012-05-10       Impact factor: 3.825

4.  Cerebral blood flow velocity in migraine and chronic tension-type headache patients.

Authors:  S Karacay Ozkalayci; B Nazliel; H Z Batur Caglayan; C Irkec
Journal:  J Pain Res       Date:  2018-04-04       Impact factor: 3.133
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.